Search results
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 3 weeks agoInterim safety and efficacy results of the Phase Ib/II Destiny-BREAST07 trial with Enhertu...
Top 15 Best-Selling Cancer Drugs
Insider Monkey via Yahoo Finance· 5 months agoIn this article, we will be discussing the top 15 best-selling cancer drugs. If you are not interested in reading about the global cancer treatment...
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation
Zacks via Yahoo Finance· 1 month agoRoche's (RHHBY) inavolisib gets Breakthrough Therapy Designation in the United States for advanced...
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 7 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
Seagen's (SGEN) Breast Cancer Study on Tuksya Combo Meets Goal
Zacks via Yahoo Finance· 10 months agoSeagen Inc. SGEN announced positive top-line results from its late-stage HER2CLIMB-02 study,...
BioNTech challenges AstraZeneca with breast cancer precision drug trial
Reuters via Yahoo News· 5 months agoBioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing...
Here's Why You May Invest in Puma Biotechnology (PBYI) Stock
Zacks via Yahoo Finance· 7 months agoPuma Biotechnology, Inc.PBYI is a biotechnology company focused on research in cancer. The company’s...
Roche (RHHBY) 1H Revenues, Earnings Down on Lower COVID-19 Test Sales
Zacks via Yahoo Finance· 11 months agoRoche Holding AG’s RHHBY performance in the first half was average, as COVID-19 product related...
Roche (RHHBY) Blood Cancer Drug Columvi Wins EC Approval
Zacks via Yahoo Finance· 11 months agoRoche RHHBY obtained conditional marketing authorization from the European Commission (EC) for its...
Seagen's (SGEN) Tukysa Gets Accelerated FDA Nod for New Indication
Zacks via Yahoo Finance· 1 year agoThe FDA grants accelerated approval to Seagen's (SGEN) Tukysa in combination with trastuzumab for...